Italiano
English
Advantages over traditional PGT tests
EmbryoGenome offers some advantages over traditional preimplantation genetic testing (PGT):
PGT-A
• 1000x higher resolution than traditional PGT-A tests;
• Detect triploidy and molar embryos (complete uniparentalisodisomy) that other labs might miss;
• Detect microdeletions + microduplications screened forduring pregnancy but missed in traditional PGT;
• Plus all traditional PGT-A features.
• Detect triploidy and molar embryos (complete uniparentalisodisomy) that other labs might miss;
• Detect microdeletions + microduplications screened forduring pregnancy but missed in traditional PGT;
• Plus all traditional PGT-A features.
PGT-M
• No customized PGT workup is necessary, resulting in faster turnaround time;
• Ideal for:
- challenging PGT-M cases that may have been denied byother companies;
- patients with a previous pregnancy/child with a de novo variant
• Can screen for hundreds of monogenic diseases simultaneously.
• Ideal for:
- challenging PGT-M cases that may have been denied byother companies;
- patients with a previous pregnancy/child with a de novo variant
• Can screen for hundreds of monogenic diseases simultaneously.
PGT-SR
• Improved resolution compared to traditional platforms used for PGT-SR;
• Increased chance of case acceptance;
• Patients can additionally screen for hundreds of monogenic conditions simultaneously;
• Includes all the features of the traditional PGT-SR
• Increased chance of case acceptance;
• Patients can additionally screen for hundreds of monogenic conditions simultaneously;
• Includes all the features of the traditional PGT-SR
EMBRYOGENOME
• Screen for hundreds of genetic conditions simultaneously;
• Detect de novo mutations, causing conditions such as skeletal dysplasias, multiple congenital anomalies, autism, epilepsy, and/or intellectual disabilities;
• Identifies genetic diseases associated with advanced paternal age;
• Plus all traditional PGT-M, PGT-A, PGT-SR features
• Detect de novo mutations, causing conditions such as skeletal dysplasias, multiple congenital anomalies, autism, epilepsy, and/or intellectual disabilities;
• Identifies genetic diseases associated with advanced paternal age;
• Plus all traditional PGT-M, PGT-A, PGT-SR features
KEY ADVANTAGES
UNMATCHED ACCURACY
With over 99% accuracy, EmbryoGenome significantly outperforms conventional PGT methods, providing the highest detection rates for genetic and chromosomal abnormalities.
COMPREHENSIVE SCREENING
EmbryoGenome combines PGT-A, PGT-M, and PGT-SR with the ability to detect hundreds of severe monogenic disorders, providing an unprecedented level of detail on the embryo's genetic profile.
ADVANCED TECHNOLOGY
EmbryoGenome uses cutting-edge technologies and sophisticated bioinformatics analyses.
ADVANCED DETECTION
Unlike standard PGT, which may overlook unexpected genetic diseases, EmbryoGenome identifies conditions that other tests often miss.
EmbryoGenome helps families maximize their chance for a successful pregnancy and healthy baby by screening embryos using whole exome sequencing.